Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Alto Ingredients
ALTO
$377M
| $38.4K | ﹤0.01% |
33,727
-697,151
| -95% | -$1.08M |
|
3427
Bridger Aerospace
BAER
$113M
| $37.3K | ﹤0.01% |
33,001
+12,500
| +61% | +$27.5K |
|
3428
Wrap Technologies
WRAP
$106M
| $36.8K | ﹤0.01% |
21,515
| – | – |
|
3429
Heritage Global
HGBL
$36.6M
| $36.6K | ﹤0.01% |
16,791
| – | – |
|
3430
Anixa Biosciences
ANIX
$116M
| $36.6K | ﹤0.01% |
12,785
| – | – |
|
3431
Babcock & Wilcox
BW
$1.51B
| $34.4K | ﹤0.01% |
51,145
| – | – |
|
3432
Ondas Inc
ONDS
$5.05B
| $34.2K | ﹤0.01% |
+32,000
| New | +$47.9K |
|
|
NOTV
3433
DELISTED
Inotiv
NOTV
| $33.1K | ﹤0.01% |
+15,000
| New | +$55K |
|
3434
KORU Medical Systems
KRMD
$194M
| $32.5K | ﹤0.01% |
12,813
| – | – |
|
3435
Milestone Scientific
MLSS
$38.5M
| $32.1K | ﹤0.01% |
34,400
| – | – |
|
3436
Vivani Medical
VANI
$115M
| $31.5K | ﹤0.01% |
30,016
| – | – |
|
3437
Seer Inc
SEER
$123M
| $30.6K | ﹤0.01% |
18,105
+238
| +1% | +$518 |
|
3438
One Stop Systems
OSS
$353M
| $30K | ﹤0.01% |
12,911
| – | – |
|
3439
Phunware
PHUN
$44.4M
| $29.5K | ﹤0.01% |
+10,000
| New | +$38.4K |
|
3440
Heartbeam
BEAT
$27.6M
| $29.2K | ﹤0.01% |
14,543
| – | – |
|
3441
NeoVolta
NEOV
$139M
| $28.1K | ﹤0.01% |
12,964
| – | – |
|
3442
Galectin Therapeutics
GALT
$200M
| $28K | ﹤0.01% |
22,913
-42,160
| -65% | -$59.1K |
|
3443
Lantronix
LTRX
$252M
| $27.7K | ﹤0.01% |
11,128
| – | – |
|
3444
RAVE Restaurant Group
RAVE
$46.6M
| $27.5K | ﹤0.01% |
10,012
| – | – |
|
3445
Immunic
IMUX
$192M
| $27.3K | ﹤0.01% |
2,500
| – | – |
|
3446
Solitario Resources
XPL
$66.5M
| $26.9K | ﹤0.01% |
44,899
| – | – |
|
3447
Zedge
ZDGE
$38.9M
| $26.4K | ﹤0.01% |
11,319
| – | – |
|
|
FARM
3448
DELISTED
Farmer Brothers
FARM
| $26.2K | ﹤0.01% |
11,781
| – | – |
|
3449
Usio Inc
USIO
$61.3M
| $26K | ﹤0.01% |
17,787
| – | – |
|
3450
Research Frontiers
REFR
$15.8M
| $24.7K | ﹤0.01% |
21,870
| – | – |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.